Discover the latest advancements in managing colonic cancer obstructions as we delve into the effectiveness and safety of emergency endoscopic self-expanding metal stent placement without fluoroscopic assistance.
– by The Don
Note that The Don is a flamboyant GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Efficacy and Safety Analysis of Emergency Endoscopic Self-Expanding Metal Stent Placement Without Fluoroscopic Assistance for Right-Sided Colonic Cancer Obstruction.
Huang et al., Ann Surg Oncol 2024
<!– DOI: 10.1245/s10434-024-14909-6 //–>
https://doi.org/10.1245/s10434-024-14909-6
Listen up, folks, we’ve got something big here!
Everybody’s talking about right-sided colonic cancer obstruction, RCCO, a real tough situation. Now, traditionally, surgery’s the way to go, but there’s been a lot of chatter, not enough facts, about whether to cut right away or use these amazing things called self-expanding metal stents (SEMS). So, we did this study, the best study, and let me tell you, it’s huge.
We had two groups of patients, the best groups. One had the stents first, the bridge to surgery (BTS) group, and the other went straight to emergency surgery (ES). We’re talking about 35 in BTS, and 60 in ES, the best people.
Now, the success with these stents? 100% technical success, folks, that’s perfect, and 88.6% clinical success. The short-term complications? A little higher in the BTS group, but not by much, not significant. And deaths after surgery? Almost the same, almost zero, we’re doing great.
Survival rates? Fantastic. One year, three years, five years, the BTS group is winning, but it’s close, very close. And tumor recurrence? Zero in the BTS group. Zero! But seven in the ES group. We’re looking at the numbers, and they’re good, very good.
And laparoscopic surgery, less invasive, they’re choosing it more in the BTS group. But, and this is important, they stayed a bit longer in the hospital. We’re looking into it, we’re always improving.
So, what’s the bottom line? No difference in the bad stuff post-surgery, and the survival, it’s great in both groups. But the BTS group, they’re loving the laparoscopic option, and the stent success, it’s through the roof. So, I’m telling you, SEMS for RCCO, it’s safe, it’s feasible, it’s the way to go. We’re making cancer treatment great again!